|
| Status |
Public on Mar 31, 2016 |
| Title |
CP61 |
| Sample type |
RNA |
| |
|
| Source name |
breast cancer tumor
|
| Organism |
Homo sapiens |
| Characteristics |
tumor size: T3
lymph node status: pos
grade: III
response: PR
tissue: breast cancer tumor
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
| Label |
biotin
|
| Label protocol |
According to whole genome DASL assay (Illumina)
|
| |
|
| Hybridization protocol |
Standard Illumina DASL hybridization protocol
|
| Scan protocol |
Standard Illumina scanning protocol
|
| Data processing |
The data were processed and normalised using quantile normalisation with BeadStudio software
|
| |
|
| Submission date |
Oct 14, 2014 |
| Last update date |
Mar 31, 2016 |
| Contact name |
Loris De Cecco |
| E-mail(s) |
loris.dececco@istitutotumori.mi.it
|
| Organization name |
IRCSS Istituto Nazionale Tumori
|
| Street address |
via Venezian 1
|
| City |
Milan |
| ZIP/Postal code |
20133 |
| Country |
Italy |
| |
|
| Platform ID |
GPL14951 |
| Series (1) |
| GSE62327 |
Gene expression profiling of primary HER2-positive breast cancers treated with neoadjuvant trastuzumab |
|
